Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.

Zahavi, Tamar; Salmon-Divon, Mali; Salgado, Roberto; Elkin, Michael; Hermano, Esther; Rubinstein, Ariel M; Francis, Prudence A; Di Leo, Angelo; Viale, Giuseppe; de Azambuja, Evandro; Ameye, Lieveke; Sotiriou, Christos; Salmon, Asher; Kravchenko-Balasha, Nataly; Sonnenblick, Amir

Zahavi, Tamar; Salmon-Divon, Mali; Salgado, Roberto; Elkin, Michael; Hermano, Esther; Rubinstein, Ariel M; Francis, Prudence A; Di Leo, Angelo; Viale, Giuseppe; de Azambuja, Evandro; Ameye, Lieveke; Sotiriou, Christos; Salmon, Asher; Kravchenko-Balasha, Nataly; Sonnenblick, Amir.

Afiliación

Zahavi T; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Salmon-Divon M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Salgado R; Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel.
Elkin M; Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel.
Hermano E; Division of Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Rubinstein AM; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.
Francis PA; Department of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Di Leo A; Department of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Viale G; The Institute of Biomedical and Oral Research, Hebrew University of Jerusalem, Jerusalem, Israel.
de Azambuja E; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
Ameye L; Breast Cancer Trials Australia & New Zealand, Newcastle, NSW, Australia.
Sotiriou C; International Breast Cancer Study Group, Bern, Switzerland.
Salmon A; Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Prato, Italy.
Kravchenko-Balasha N; The University of Milan, and IEO European Institute of Oncology IRCCS, Milan, Italy.
Sonnenblick A; Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.

NPJ Breast Cancer ; 7(1): 67, 2021 May 28.

Article en En | MEDLINE | ID: mdl-34050190

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: NPJ Breast Cancer Año: 2021 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google